Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients.
Zhang Z, Wu S, Liu Y, Li K, Fan P, Song X, Wang Y, Zhao Z, Zhang X, Shang J, Zhang J, Xu J, Li Y, Li Y, Zhang J, Fu K, Wang B, Hao M, Zhang G, Long P, Qiu Z, Zhu T, Liu S, Zhang Y, Shao F, Lv P, Yang Y, Zhao X, Sun Y, Hou L, Chen W.
Zhang Z, et al. Among authors: yang y.
Front Immunol. 2023 Oct 4;14:1239179. doi: 10.3389/fimmu.2023.1239179. eCollection 2023.
Front Immunol. 2023.
PMID: 37868993
Free PMC article.
Clinical Trial.